HemOnc Today Current Issue
The following articles appeared in the print edition of HemOnc Today.
Table of Contents
- AIDS no longer an obstacle to effective cancer treatment
-
- ACS: Progress continues in cancer death prevention
- Economic factors linked to increase in ED closures
- Five loci associated with increased susceptibility for cutaneous melanoma
- HPV vaccination program linked to decreases in cervical abnormalities in Australian population
- Low-dose CT screening reduced lung cancer mortality 20%
- Re-induction therapy plus autologous stem cell transplant effective in pediatric ALCL
- STOP II: Prophylactic transfusions prevented silent brain infarction in pediatric sickle cell disease
- Computer-assisted melanoma surveillance may play larger role in clinical practice
-
- Crizotinib improved survival in advanced, ALK-positive NSCLC
- High-dose methotrexate improved EFS in children, adolescents with ALL
- HR-NLB1: Busulphan/melphalan improved 3-year OS to 60% in pediatric neuroblastoma
- Immune response predicts improved survival in Merkel cell carcinoma
- NORDIC: No OS benefit with intermediate-dose interferon alfa-2b in melanoma
- Studies validate conventional wisdom to lower melanoma risk
- Targeted therapies becoming a treatment option for advanced basal cell carcinoma
- Communicating with children when a parent is dying Maria Rueda-Lara, MD
-
- A pharmacokinetic and pharmacodynamic review of single-dose fosaprepitant 150 mg Tiffany Capouch, PharmD